180 related articles for article (PubMed ID: 2765677)
1. Clinical significance of fibrinopeptide A in acute lymphocytic and non-lymphocytic leukaemia.
Rodeghiero F; Castaman G; Soffiati G; Quaglio R; Castronovo S; Cortesi S; Dini E
Blut; 1989 Aug; 59(2):177-83. PubMed ID: 2765677
[TBL] [Abstract][Full Text] [Related]
2. High fibrinopeptide A (FPA) levels in acute non-lymphocytic leukemia are reduced by heparin administration.
Gugliotta L; Viganò S; D'Angelo A; Guarini A; Tura S; Mannucci PM
Thromb Haemost; 1984 Dec; 52(3):301-4. PubMed ID: 6531754
[TBL] [Abstract][Full Text] [Related]
3. Fibrinopeptide A in acute leukemia: relationship of activation of blood coagulation to disease activity.
Myers TJ; Rickles FR; Barb C; Cronlund M
Blood; 1981 Mar; 57(3):518-25. PubMed ID: 6936055
[TBL] [Abstract][Full Text] [Related]
4. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
Murakoshi T
Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
[TBL] [Abstract][Full Text] [Related]
5. Thrombin generation in acute promyelocytic leukemia.
Bauer KA; Rosenberg RD
Blood; 1984 Oct; 64(4):791-6. PubMed ID: 6592007
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of various types of acute leukemia in adult. An analysis of 98 cases. The Leukemia Cooperation Group of Beijing City].
Zhonghua Nei Ke Za Zhi; 1992 Mar; 31(3):139-42, 187. PubMed ID: 1395923
[TBL] [Abstract][Full Text] [Related]
7. [Fibrinogen metabolism and plasma fibrinopeptide A in disseminated neoplasms].
Mombelli G; Roux A; Hofmann V; Straub PW
Schweiz Med Wochenschr; 1979 Dec; 109(47):1901. PubMed ID: 531571
[TBL] [Abstract][Full Text] [Related]
8. [Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia].
Meng FY; Yang LJ; Xu B; Liu XL; Zheng WY; Zhang Y; Huang F; Sun J; Liu QF
Ai Zheng; 2003 Dec; 22(12):1330-3. PubMed ID: 14693062
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of 58 patients with acute leukemia].
Sasaki A; Tsukaguchi M
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1303-7. PubMed ID: 1503484
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen survival and fibrinopeptide A in acute leukemia.
Castaman G; Galloni E; Dri AV; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow response to chemotherapy in acute lymphocytic leukaemia and acute non-lymphocytic leukaemia.
Brody JP; Krause JR; Penchansky L
Scand J Haematol; 1985 Aug; 35(2):240-5. PubMed ID: 3863236
[TBL] [Abstract][Full Text] [Related]
12. Long-term prognosis of children with Down's syndrome and leukaemia: a 34-year nation-wide experience.
Rajantie J; Siimes MA
J Intellect Disabil Res; 2003 Nov; 47(Pt 8):617-21. PubMed ID: 14641809
[TBL] [Abstract][Full Text] [Related]
13. Disseminated intravascular coagulation (DIC) in adult patients with acute leukaemia.
Sletnes KE; Godal HC; Wisløff F
Eur J Haematol; 1995 Jan; 54(1):34-8. PubMed ID: 7859873
[TBL] [Abstract][Full Text] [Related]
14. [The treatment of disseminated intravascular coagulation in 18 cases of promyelocytic acute leukaemia (author's transl)].
Dreyfus B; Varet B; Heilmann-Gouault M; Sultan C; Reyes F; Gluckman E; Basch A; Beaujean F
Nouv Rev Fr Hematol; 1973; 13(6):761-70. PubMed ID: 4280042
[No Abstract] [Full Text] [Related]
15. Significance of plasma fibrinopeptide A (fpA) in patients with malignancy.
Peuscher FW; Cleton FJ; Armstrong L; Stoepman-van Dalen EA; van Mourik JA; van Aken WG
J Lab Clin Med; 1980 Jul; 96(1):5-14. PubMed ID: 7391657
[TBL] [Abstract][Full Text] [Related]
16. Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German results.
Linkesch W; Michlmayr G; Gerhartz H; Illinger H; König H; Düllmann J; Keilhauer R; Moldrzyk D
Onkologie; 1989 Feb; 12(1):8-10. PubMed ID: 2654791
[TBL] [Abstract][Full Text] [Related]
17. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
Mombelli G; Monotti R; Haeberli A; Straub PW
Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
[TBL] [Abstract][Full Text] [Related]
18. Fibrinopeptide A changes during remission induction treatment with L-asparaginase in acute lymphoblastic leukemia: evidence for activation of blood coagulation.
Rodeghiero F; Castaman G; Dini E
Thromb Res; 1990 Jan; 57(1):31-8. PubMed ID: 2300923
[TBL] [Abstract][Full Text] [Related]
19. Coincidence of acquired factor-X deficiency and disseminated intravascular coagulation in patients with acute nonlymphoblastic leukemia.
Pabinger I; Bettelheim P; Dudczak R; Hinterberger W; Kyrle PA; Niessner H; Schwarzinger I; Speiser W; Lechner K
Ann Hematol; 1991 May; 62(5):174-9. PubMed ID: 2049464
[TBL] [Abstract][Full Text] [Related]
20. Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy.
Dixit A; Chatterjee T; Mishra P; Kannan M; Choudhry DR; Mahapatra M; Choudhry VP; Saxena R
Clin Appl Thromb Hemost; 2007 Jul; 13(3):292-8. PubMed ID: 17636191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]